Cetuximab concurrent with IMRT versus cisplatin concurrent with IMRT in locally advanced nasopharyngeal carcinoma: A retrospective matched case–control study

To evaluate the treatment efficacies and toxicities of concurrent cetuximab-based bioradiotherapy (BRT) or cisplatin-based chemoradiotherapy (CRT) in locally advanced nasopharyngeal carcinoma. :Patients with previously untreated locally advanced nasopharyngeal carcinoma were matched into pairs, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Wu, Xin, Huang, Jingwen, Liu, Lei, Li, Hongmei, Li, Ping, Zhang, Jing, Xie, Li
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2016
Matèries:
5700
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5265923/
https://ncbi.nlm.nih.gov/pubmed/27684830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004926
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars